Quick Answer
BIOCRYST PHARMACEUTICALS INC reported Total Revenue of $25.19 million for fiscal year 2017.
BIOCRYST PHARMACEUTICALS INC Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2017 | $25.19M | -4.4% |
| 2016 | $26.35M | -45.4% |
| 2015 | $48.26M | +254.6% |
| 2014 | $13.61M | -21.5% |
| 2013 | $17.33M | -34.1% |
| 2012 | $26.29M | +33.9% |
| 2011 | $19.64M | -68.5% |
| 2010 | $62.38M | -16.4% |
| 2009 | $74.59M | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2017 | $8.76M | +12.8% | +182.7% |
| June 30, 2017 | $3.10M | -35.3% | -67.2% |
| March 31, 2017 | $9.44M | +95.8% | +21.6% |
| September 30, 2016 | $7.76M | -29.3% | +62.2% |
| June 30, 2016 | $4.79M | -81.5% | -0.7% |
| March 31, 2016 | $4.82M | -29.4% | -56.1% |
| September 30, 2015 | $10.99M | +239.3% | -57.5% |
| June 30, 2015 | $25.84M | +1662.8% | +278.6% |
- BIOCRYST PHARMACEUTICALS INC showed a decrease of -4.4% in Total Revenue compared to the prior fiscal year.
- Over the 2009–2017 period, BIOCRYST PHARMACEUTICALS INC’s total revenue has declined by 66.2% (from $74.59 million to $25.19 million).
- The most recent figure is from BIOCRYST PHARMACEUTICALS INC’s fiscal year 2017 report (Form 10-K), filed with the SEC on March 12, 2018.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: